Effects of consumption of the beverage containing fulvic acid and silicon on fatigue and sleep quality in healthy Japanese subjects who have received mRNA vaccination for COVID-19 at least three times: a randomized, placebo-controlled, parallel-group comparison study - Effects of consumption of the beverage containing fulvic acid and silicon on fatigue and sleep quality in healthy Japanese subjects who have received mRNA vaccination for COVID-19 at least three times

ORTHOMEDICO Inc.0 个研究点目标入组 84 人开始时间: 2023年9月12日最近更新: 2024年9月2日

适应症

试验速览

暂无简介。

•1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 5. Subjects who are currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products 7. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 8. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 9. Subjects who are judged as ineligible to participate in this study by the physician

发起方